MARY WALKER: Open Payments
NPI 1023051067 · MADISONVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 29 payments from 11 companies in 2025. Trend: 2023 $980 · 2024 $705 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 6 | $133 |
| Lilly USA, LLC | 7 | $121 |
| Novo Nordisk Inc | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: Leqembi, KISUNLA, REXULTI, GEMTESA, Rybelsus, Kerendia, TRELEGY ELLIPTA, INGREZZA.
Industry payments across TN — which companies pay providers there.
